000513 丽珠集团
交易中 08-13 11:25:18
资讯
新帖
简况
股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》
证券之星 · 08-10
股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》
每周股票复盘：丽珠集团（000513）为子公司担保6.52亿元
证券之星 · 08-09
每周股票复盘：丽珠集团（000513）为子公司担保6.52亿元
股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》
证券之星 · 08-07
股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》
丽珠集团（000513）披露董事会会议安排，8月6日股价下跌0.79%
证券之星 · 08-06
丽珠集团（000513）披露董事会会议安排，8月6日股价下跌0.79%
丽珠集团（000513）披露为子公司提供担保的进展公告，8月5日股价下跌1.46%
证券之星 · 08-05
丽珠集团（000513）披露为子公司提供担保的进展公告，8月5日股价下跌1.46%
股市必读：丽珠集团新发布《H股公告：证券变动月报表》
证券之星 · 08-05
股市必读：丽珠集团新发布《H股公告：证券变动月报表》
丽珠集团（000513）披露截至2026年7月31日证券变动月报表，8月4日股价下跌0.64%
证券之星 · 08-04
丽珠集团（000513）披露截至2026年7月31日证券变动月报表，8月4日股价下跌0.64%
每周股票复盘：丽珠集团（000513）获中药新药注册证书
证券之星 · 07-26
每周股票复盘：丽珠集团（000513）获中药新药注册证书
丽珠集团（000513）披露子公司获得《药品注册证书》，7月23日股价下跌0.58%
证券之星 · 07-23
丽珠集团（000513）披露子公司获得《药品注册证书》，7月23日股价下跌0.58%
每周股票复盘：丽珠集团（000513）H股及A股股本无变动
证券之星 · 07-05
每周股票复盘：丽珠集团（000513）H股及A股股本无变动
丽珠集团（000513）披露证券变动月报表，7月2日股价上涨1.08%
证券之星 · 07-02
丽珠集团（000513）披露证券变动月报表，7月2日股价上涨1.08%
6月29日丽珠集团涨5.10%，方正富邦趋势领航混合A基金重仓该股
证券之星 · 06-29
6月29日丽珠集团涨5.10%，方正富邦趋势领航混合A基金重仓该股
丽珠集团涨5.10%，东海证券二个月前给出“买入”评级
证券之星 · 06-29
丽珠集团涨5.10%，东海证券二个月前给出“买入”评级
每周股票复盘：丽珠集团（000513）丽珠单抗重组人促卵泡激素获批上市
证券之星 · 06-07
每周股票复盘：丽珠集团（000513）丽珠单抗重组人促卵泡激素获批上市
港股公告掘金 | 智谱拟发行A股并在科创板上市
智通财经 · 06-02
港股公告掘金 | 智谱拟发行A股并在科创板上市
丽珠集团自愿公告：来坎基图格注射液上市许可申请获中国国家药监局受理
美股速递 · 06-01
丽珠集团自愿公告：来坎基图格注射液上市许可申请获中国国家药监局受理
丽珠集团(000513.SZ)：子公司重组人促卵泡激素注射液获得《药品注册证书》
智通财经 · 06-01
丽珠集团(000513.SZ)：子公司重组人促卵泡激素注射液获得《药品注册证书》
丽珠集团最新公告：莱康奇塔单抗注射液上市许可申请获国家药监局受理
证券之星 · 06-01
丽珠集团最新公告：莱康奇塔单抗注射液上市许可申请获国家药监局受理
丽珠集团（000513）新增【AI智能体】概念
证券之星 · 05-25
丽珠集团（000513）新增【AI智能体】概念
每周股票复盘：丽珠集团（000513）将参加2025年度集体业绩说明会
证券之星 · 05-17
每周股票复盘：丽珠集团（000513）将参加2025年度集体业绩说明会
加载更多
公司概况
公司名称：
丽珠医药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-10-28
主营业务：
丽珠医药集团股份有限公司的主营业务是医药产品的研发、生产及销售。公司的主要产品是化学制剂产品、原料药及中间体产品、中药制剂产品、生物制品、诊断试剂及设备。截至2025年12月31日，公司累计拥有国内外有效授权专利991项，其中发明专利523项。
发行价格：
6.38
{"stockData":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":30.9,"timestamp":1786591518000,"preClose":30.6,"halted":0,"volume":4653286,"delay":0,"changeRate":0.0098,"floatShares":568000000,"shares":888000000,"eps":2.2114,"marketStatus":"交易中","change":0.3,"latestTime":"08-13 11:25:18","open":30.5,"high":30.95,"low":30.18,"amount":142000000,"amplitude":0.0252,"askPrice":30.92,"askSize":78,"bidPrice":30.91,"bidSize":32,"shortable":0,"etf":0,"ttmEps":2.2114,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786591800000},"marketStatusCode":2,"adr":0,"adjPreClose":30.6,"symbolType":"stock","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":33.66,"lowLimit":27.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":887907171,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":13.973049,"roe":"4.06%","epsLYR":2.27,"committee":-0.436323,"marketValue":27436000000,"turnoverRate":0.0082,"status":0,"hkstockBrief":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":26.36,"timestamp":1786591513401,"preClose":26.32,"halted":0,"volume":218100,"delay":0,"premium":"-26.67"},"floatMarketCap":17556000000},"requestUrl":"/m/hq/s/000513","defaultTab":"news","newsList":[{"id":"2658670204","title":"股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670204","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670204?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:48","pubTimestamp":1786297692,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，丽珠集团报收于30.68元，上涨1.83%，换手率1.23%，成交量7.01万手，成交额2.14亿元。当日关注点交易信息汇总：8月7日主力资金净流入722.87万元，占总成交额3.38%。公司公告汇总：丽珠集团董事会定于2026年8月21日审议截至2026年6月30日止六个月的未经审计半年度业绩。公告由公司秘书刘宁于2026年8月6日发出，并列示了截至公告日期的董事名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0187","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673040","title":"每周股票复盘：丽珠集团（000513）为子公司担保6.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673040","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673040?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:17","pubTimestamp":1786213029,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，丽珠集团报收于30.68元，较上周的31.13元下跌1.45%。本周，丽珠集团8月3日盘中最高价报31.34元。本周关注点公司公告汇总：丽珠集团为多家子公司提供担保，总额达65,200万元。公司公告汇总丽珠医药集团股份有限公司提交截至2026年7月31日的证券变动月报表，显示公司H股和A股的法定注册资本及已发行股份均无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","000513","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657156659","title":"股市必读：丽珠集团新发布《H股公告：董事会会议召开日期》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657156659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657156659?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:30","pubTimestamp":1786037433,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，丽珠集团报收于30.13元，下跌0.79%，换手率0.97%，成交量5.5万手，成交额1.66亿元。公司公告汇总：丽珠集团董事会定于2026年8月21日审议截至2026年6月30日止六个月的未经审计半年度业绩。公告同时列出了截至公告日期的董事名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","000513","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657762630","title":"丽珠集团（000513）披露董事会会议安排，8月6日股价下跌0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657762630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657762630?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:27","pubTimestamp":1786026435,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，丽珠集团报收于30.13元，较前一交易日下跌0.79%，最新总市值为267.53亿元。该股当日开盘30.45元，最高30.5元，最低29.94元，成交额达1.66亿元，换手率为0.97%。近日，丽珠医药集团股份有限公司发布公告称，公司董事会定于2026年8月21日（星期五）举行董事会会议，审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审计半年度业绩，以及处理其他事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600039982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0187","BK0188","000513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517288","title":"丽珠集团（000513）披露为子公司提供担保的进展公告，8月5日股价下跌1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517288","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657517288?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:41","pubTimestamp":1785922916,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，丽珠集团报收于30.37元，较前一交易日下跌1.46%，最新总市值为269.66亿元。该股当日开盘30.7元，最高30.77元，最低30.27元，成交额达2.19亿元，换手率为1.27%。丽珠医药集团股份有限公司于2026年7月为多家子公司提供担保，涉及丽珠制药厂、四川光大、珠海医贸、宁夏公司、新北江制药及焦作合成，担保金额合计65,200万元，担保形式为连带责任保证。相关担保事项已履行董事会及股东会审议程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0187","BK0188","000513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756518","title":"股市必读：丽珠集团新发布《H股公告：证券变动月报表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657756518?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:55","pubTimestamp":1785869712,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年7月31日，丽珠集团H股与A股已发行股份均无变动，库存股为零。公司公告汇总：截至2026年7月31日，公司实际对外担保余额165,365.65万元，占最近一期经审计净资产的11.91%，均为对子公司的连带责任保证，无逾期及对外担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0028","BK0239","BK0187","BK0188","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656310975","title":"丽珠集团（000513）披露截至2026年7月31日证券变动月报表，8月4日股价下跌0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656310975","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656310975?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:57","pubTimestamp":1785837458,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，丽珠集团报收于30.82元，较前一交易日下跌0.64%，最新总市值为273.65亿元。公司于近日披露《证券变动月报表》，显示截至2026年7月31日，丽珠医药集团股份有限公司H股总数为299,807,117股，于香港联交所上市；A股总数为588,100,054股，于深圳证券交易所上市。H股和A股的法定注册资本及已发行股份均无变动，库存股数量为零。本月无股份增减变动，所有披露事项均已获董事会批准并遵守相关法规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400030396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0028","BK0187","BK0239","000513","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654806057","title":"每周股票复盘：丽珠集团（000513）获中药新药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2654806057","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654806057?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:05","pubTimestamp":1785002714,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，丽珠集团报收于29.96元，较上周的30.59元下跌2.06%。本周，丽珠集团7月21日盘中最高价报31.48元。丽珠集团当前最新总市值266.02亿元，在化学制药板块市值排名14/149，在两市A股市值排名691/5200。该药品是公司首款获批的中药3.1类新药，累计研发投入约501.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0187","BK0239","000513","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653729965","title":"丽珠集团（000513）披露子公司获得《药品注册证书》，7月23日股价下跌0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653729965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653729965?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:41","pubTimestamp":1784817672,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，丽珠集团报收于30.72元，较前一交易日下跌0.58%，最新总市值为272.77亿元。该股当日开盘30.66元，最高30.85元，最低30.36元，成交额达1.64亿元，换手率为0.95%。近日，丽珠医药集团股份有限公司发布公告称，其子公司四川光大制药有限公司收到国家药品监督管理局签发的《药品注册证书》，批准半夏白术天麻汤颗粒上市。该药品是公司首款获批的中药3.1类新药，累计研发投入约501.02万元。该事项不会对公司近期经营业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","000513","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692391","title":"每周股票复盘：丽珠集团（000513）H股及A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692391","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692391?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:21","pubTimestamp":1783192871,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，丽珠集团报收于30.39元，较上周的28.43元上涨6.89%。本周，丽珠集团7月3日盘中最高价报30.43元。丽珠集团当前最新总市值269.83亿元，在化学制药板块市值排名15/149，在两市A股市值排名801/5203。本周关注点公司公告汇总：丽珠集团H股及A股法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，证券代码01513，A股于深圳证券交易所上市，证券代码000513。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0028","399300","BK0188","000513","BK0239","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648686941","title":"丽珠集团（000513）披露证券变动月报表，7月2日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648686941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648686941?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:44","pubTimestamp":1783003458,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，丽珠集团报收于29.97元，较前一交易日上涨1.08%，最新总市值为266.11亿元。近日，丽珠医药集团股份有限公司提交截至2026年6月30日的证券变动月报表。公告显示，公司普通股H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，证券代码01513，A股于深圳证券交易所上市，证券代码000513。已发行股份总数未发生变化，且无库存股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000513","BK0187","BK0239","161027","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647432267","title":"6月29日丽珠集团涨5.10%，方正富邦趋势领航混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647432267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647432267?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:48","pubTimestamp":1782722885,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日丽珠集团涨5.10%创60日新低，收盘报29.88元，换手率1.53%，成交量8.69万手，成交额2.54亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为方正富邦基金的方正富邦趋势领航混合A。方正富邦趋势领航混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0187","000513","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322590","title":"丽珠集团涨5.10%，东海证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647322590?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:47","pubTimestamp":1782722875,"startTime":"0","endTime":"0","summary":"今日丽珠集团涨5.10%，收盘报29.88元。2026年4月6日，东海证券研究员杜永宏发布了对丽珠集团的研报《公司简评报告：业绩总体平稳，创新研发快速推进》，该研报对丽珠集团给出“买入”评级。公司经营稳健，产品管线持续丰富，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的宋歌。丽珠集团个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641212741","title":"每周股票复盘：丽珠集团（000513）丽珠单抗重组人促卵泡激素获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2641212741","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641212741?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:53","pubTimestamp":1780771988,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，丽珠集团报收于30.66元，较上周的30.86元下跌0.65%。本周关注点公司公告汇总：重组人促卵泡激素注射液（丽优宝）获国家药监局批准上市。关于获得《药品注册证书》的公告丽珠医药集团股份有限公司子公司珠海市丽珠单抗生物技术有限公司收到国家药品监督管理局签发的《药品注册证书》，批准其自主研发的重组人促卵泡激素注射液上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0028","BK0239","BK0187","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995865","title":"港股公告掘金 | 智谱拟发行A股并在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995865","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640995865?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:00","pubTimestamp":1780362051,"startTime":"0","endTime":"0","summary":"重大事项：丽珠医药：重组人促卵泡激素注射液获得《药品注册证书》山东新华制药股份：获得碳酸司维拉姆干混悬剂药品注册证书白云山：白云山制药总厂收到国家药监局核准签发的关于磷酸奥司他韦干混悬剂的《药品注册证书》智谱拟发行A股并在科创板上市驭势科技：与赛力斯凤凰智创完成行泊一体乘用车海外量产及交付澜起科技：横琴公司拟进行增资扩股并引入新投资方 引资合共约5亿元股东持续赋能!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0067412154.USD","LU0871576103.HKD","BK1142","LU0054237671.USD","LU0210526637.USD","00719","LU0650527681.SGD","SG9999015978.USD","LU0345775950.USD","LU0979878070.USD","METmain","LU0254981946.USD","NIO","LU1282651121.HKD","LU0326950275.SGD","LU2488822045.USD","LU1188198961.HKD","LU0320764599.SGD","BK1583","LU0633140560.USD","LU0348814723.USD","LU0259732245.USD","LU0499858602.USD","LU1770036033.HKD","LU1861219969.SGD","BK1521","SG9999000459.SGD","LU0048597586.USD","LU0287142896.SGD","BK1119","LU2476274720.SGD","02513","BK1587","LU0315178854.USD","601127","LU1328277881.USD","LU0417516738.SGD","LU0132412106.USD","BK1604","LU1720050803.USD","LU0577902538.SGD","LU0228659784.USD","02333","LU0516422366.SGD","LU1813983027.USD","BK1589","LU1242518931.SGD","00874","LU0320764243.SGD","IE0008368742.USD","LU2249611893.SGD","LU1960683339.HKD","LU0326948709.USD","LU0511384066.AUD","BK1575","BK1515","LU0683595622.HKD","LU2242644610.SGD","LU2357125470.USD","GELYY","LU0594300419.USD","BK1221","NIO.SI","01511","XPEV","LU0531971595.HKD","07489","LU1719994722.HKD","BK1233","LU0140636845.USD","LU0370786039.SGD","LU0516423174.USD","LU0823426480.USD","LU0593848301.USD","LU0823426308.USD","LU0611395673.USD","LU0823414551.USD","LU0540923850.HKD","LU0708995153.HKD","LU0588545904.SGD","LU0531970944.HKD","000756","LU0577902611.USD","LU1880383440.USD","LU0819123356.HKD","LU1961090484.USD","09868","LU2294711713.HKD","LU0320764755.SGD","LU0577902371.SGD","LU0868486357.SGD","HYDD.SI","LU0251144936.SGD","LU1251922891.USD","IE00B543WZ88.USD","GWLLY","01513","LU0605514214.HKD","LU1282648689.USD","00175","000513","LU0543330566.HKD","LU2097828557.USD","LU1861214812.USD","SG9999015945.SGD","LU0502904849.HKD","600332","LU0541501648.USD","LU1064130708.USD","LU0289739343.SGD","BK1197","LU0737861699.HKD","BK1191","LU1675838814.USD","IE00B29SXG58.USD","LU1226287529.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","09973","LU0449509016.USD","LU0106252389.USD","LU1868837722.USD","LU0588546209.SGD","LU0856984785.SGD","LU0431992006.USD","LU0505663152.USD","LU0348735423.USD","SG9999014674.SGD","LU0541502299.USD","BYDDY","LU0164880469.USD","LU0054450605.USD","LU1481107354.HKD","LU2506951792.HKD","LU0149721374.USD","BK1606","LU1023057109.AUD","LU0196878994.USD","LU2097828631.EUR","BK1618","LU2153592121.USD","BK1594","BK1591","LU0634319403.HKD","LU0594300179.USD","LU0128522744.USD","LU0047713382.USD","LU0588545730.USD","BK1509","BK1522","IE00BZ08YT58.USD","LU0143863784.USD","LU0588545490.SGD","SG9999002562.SGD","LU1734074674.USD","BK1582","LU1328615791.USD","LU0516422440.USD","LU1048588211.SGD","LU0456846285.SGD","LU0359202008.SGD","LU0084288322.USD","LU1064131003.USD","002594","LU1831875114.USD","601633","LU0455707207.USD","LU0039217434.USD","LU0577902454.USD","LU0072462343.USD","LU0048580855.USD","LU2125910500.SGD","LU1993786604.SGD","80175","LU0918141705.HKD","LU1688375341.USD","LU0214875030.USD","IE00B3M56506.USD","LU1102505929.USD","LU0348825331.USD","LU0878005551.USD","LU2097828714.EUR","LU2148510915.USD","SG9999002828.SGD","LU0315179316.USD","LU0229945570.USD","LU0348788117.USD","LU1794554557.SGD","LU0029875118.USD","01211","LU0543330483.HKD","BK1117","IE00B5MMRT66.SGD","LU1105468828.SGD","IE00BPRC5H50.USD","LU0918141887.USD","LU0417516902.SGD","LU0865486749.SGD","LU0456827905.SGD","SG9999001903.USD","LU0011963245.USD","LU0572944931.SGD","06809","LU0828237510.HKD","BK1615","LU0672654166.SGD","LU1808992512.USD","LU0348816934.USD","LU0175139822.USD","LU0823041008.USD","IE0032431581.USD","LU0072913022.USD","02886","SG9999015952.SGD","LU0164865239.USD","LU1152091168.USD","LU1152091754.HKD","SG9999000327.SGD","81211","LU1880383366.USD","LU0173614495.USD","SG9999002463.SGD","BK1539","LU0821914370.USD","LU0577902298.EUR","LU1242518857.USD","LU0117841782.USD","BK1163","LU0359201885.HKD","LU0509642566.USD","LU0269904917.USD","LU0873338254.USD","IE00BF5LJ272.USD","LU2097828474.EUR","LU2348774022.SGD","LU1224444064.USD","LU0700851271.USD","SG9999001226.SGD","LU0449515922.USD","LU0797268264.HKD","LU0561508036.HKD","LU2039709279.SGD","LU0261950983.USD","LU0289961442.SGD","LU1048596156.SGD","IE00BD6J9T35.USD","09927","LU2226246903.HKD","SG9999015986.USD","LU2360107325.USD","IE00B031HY20.USD","LU0181495838.USD","03690","LU0516423091.SGD","LU2399975544.HKD","BK1610","SG9999006514.SGD","EVS.SI","LU0052750758.USD","LU0823038988.USD","SG9999006597.SGD","LU0029874905.USD","LU0823039010.USD","LU0345776255.USD","LU1303224171.USD","LU0828237940.HKD","IE0034224299.USD","LU0289960550.SGD","LU1008478684.HKD","LU0211977185.USD","IE00B0JY6N72.USD","LU0327786744.USD","LU2045819591.USD","LU0314109678.HKD","82333","LU2087589342.USD","LU1868837565.USD","LU0043850808.USD","LU0501845795.SGD","LU0469268626.HKD","LU0293314216.USD","LU2476274308.USD","LU0128522157.USD","LU0051755006.USD","LU0633140727.USD","LU0164872284.USD","LU0244354667.USD","LU2257852520.SGD","LU0165289439.USD","LU0819121731.USD","LU0828238088.HKD","LU1224709979.USD","BK1588","LU0143863198.USD","LU0307460666.USD","LU1102505762.USD","LU1323998911.USD","LU0348827113.USD","LU1868838027.USD","LU0231483743.USD","IE0008369823.USD","HMTD.SI","LU0589944569.HKD","LU0823040885.USD","LU0463099449.HKD","LU0880133367.SGD","LU2449936058.SGD","LU0708995583.HKD","LU1807302812.USD","LU2152927971.USD","MPNGY","LU0049853897.USD","LU0823414478.USD","09866","LU2778985437.USD","BK1540","LU0516422952.EUR","LU2097828805.USD","688008","LU0348805143.USD","LU0499858438.USD","LU1282651048.USD","SG9999001689.USD","LU1770034418.SGD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198333193","title":"丽珠集团自愿公告：来坎基图格注射液上市许可申请获中国国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1198333193","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198333193?lang=zh_cn&edition=full","pubTime":"2026-06-01 21:54","pubTimestamp":1780322053,"startTime":"0","endTime":"0","summary":"丽珠集团自愿发布公告称，其研发的来坎基图格注射液的上市许可申请，已正式获得中国国家药品监督管理局的受理，进入审评阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","000513","BK0187","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640593219","title":"丽珠集团(000513.SZ)：子公司重组人促卵泡激素注射液获得《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2640593219","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640593219?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:40","pubTimestamp":1780314046,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠集团 发布公告，近日，公司子公司珠海市丽珠单抗生物技术有限公司收到国家药品监督管理局签发的重组人促卵泡激素注射液《药品注册证书》。公告显示，重组人促卵泡激素注射液由丽珠单抗自主研发，本次注册申请的适应症为：无排卵且对枸橼酸克罗米酚治疗无反应的妇女。严重缺乏促黄体激素和促卵泡激素的患者，即内源性的血清LH水平<1.2IUL的患者。推荐LH与FSH联合使用以刺激卵泡的发育。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000513","BK0239","BK0187","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640008953","title":"丽珠集团最新公告：莱康奇塔单抗注射液上市许可申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640008953","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640008953?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:41","pubTimestamp":1780310476,"startTime":"0","endTime":"0","summary":"丽珠集团(000513.SZ)公告称，公司子公司丽珠单抗与北京鑫康合联合开发的莱康奇塔单抗注射液上市许可申请获国家药监局受理，拟定适应症为强直性脊柱炎。该药品为治疗用生物制品1类，采用每4周皮下注射方案，关键III期临床研究显示疗效明确、安全性良好。截至公告日，累计研发投入约2.17亿元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100031689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0239","BK0028","000513","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585935","title":"丽珠集团（000513）新增【AI智能体】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638585935?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:30","pubTimestamp":1779712223,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，5月25日丽珠集团新增概念。丽珠集团主营业务：主要从事医药产品的研发、生产和销售业务的中国公司。丽珠集团2026年一季报显示，一季度公司主营收入28.71亿元，同比下降9.73%；归母净利润5.77亿元，同比下降9.39%；扣非净利润5.79亿元，同比下降6.48%；负债率35.59%，投资收益3292.65万元，财务费用-312.29万元，毛利率65.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0188","BK0028","159819","BK0239","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061154","title":"每周股票复盘：丽珠集团（000513）将参加2025年度集体业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061154","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636061154?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:09","pubTimestamp":1778954951,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，丽珠集团报收于30.88元，较上周的32.03元下跌3.59%。本周，丽珠集团5月11日盘中最高价报32.48元。丽珠集团当前最新总市值274.19亿元，在化学制药板块市值排名14/150，在两市A股市值排名814/5203。本周关注点公司公告汇总：丽珠集团将参加深圳证券交易所组织的2025年度集体业绩说明会。公司公告汇总丽珠医药集团股份有限公司将于2026年5月21日15:00-17:00参加由深圳证券交易所组织的“深研发求精进·积蓄医药成长新动能”2025年度集体业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0187","BK0239","000513","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786591521908,"stockEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0036},{"period":"3month","weight":0.02},{"period":"6month","weight":-0.0799},{"period":"1year","weight":-0.2003},{"period":"ytd","weight":-0.0703}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"丽珠医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"59444人(较上一季度增加2.14%)","perCapita":"9557股","listingDate":"1993-10-28","address":"广东省珠海市金湾区创业北路38号总部大楼","registeredCapital":"88790万元","survey":" 丽珠医药集团股份有限公司的主营业务是医药产品的研发、生产及销售。公司的主要产品是化学制剂产品、原料药及中间体产品、中药制剂产品、生物制品、诊断试剂及设备。截至2025年12月31日，公司累计拥有国内外有效授权专利991项，其中发明专利523项。","listedPrice":6.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠集团(000513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠集团(000513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠集团,000513,丽珠集团股票,丽珠集团股票老虎,丽珠集团股票老虎国际,丽珠集团行情,丽珠集团股票行情,丽珠集团股价,丽珠集团股市,丽珠集团股票价格,丽珠集团股票交易,丽珠集团股票购买,丽珠集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠集团(000513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠集团(000513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}